• Home
    • History
    • Educational Endowment Fund
    • Distinguished Achievement Award
    • The NEOS Logo
    • Board and Committees
  • Public Information
  • Meetings
    • General Information
    • Upcoming Physician Meeting
    • Ophthalmic Medical Personnel Meeting
    • Ophthalmic Administrators Meeting
    • Future Meeting Registration & Submission
    • NEOS Exhibitors
    • Past Meeting Abstracts & Videos
  • Become a Member
  • Members
  • Exhibitors
    • 2019-2020 Online Registration
    • 2018-2019 Online Registration
    • Invitation 2019-2020
    • 2019-2020 PDF Registration form
  • Donate

April 11, 2014 Meeting Conference

Retina

Diabetic Macular Edema 2014: Who gets treated and with what?
Scott M. Steidl

Pharmacotherapeutic Management of Exudative AMD II: Which Maintenance Regimen?
Elias Reichel

AREDS 2: Did we learn anything?
Ivana K. Kim

Compounding Pharmacies – Where Do We Stand?
Trexler M. Topping

The Pharmacotherapeutic Management of Exudative AMD I: Which Drug?
Ron Adelman

The Evoluation of Pharmacotherapy for Retinal Venous Occlusive Disease
Julia Haller

The Vitreomacular Interface: Pharmacological Targeting
Julia Haller

ROP: Origins of long term effects on retinal and visual function
Anne B. Fulton

 
New England Ophthalmological Society, Inc. PO Box 6305, Boston, MA 02114 - neosjudy@aol.com - www.neos-eyes.org

Conference Management Software by X-CD Technologies Inc.

Conference Management Software by X-CD Technologies Inc.

Tech Support